Opaleye Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-597,500
| Closed | -$5.57M | – | 54 |
|
|
2023
Q2 | $5.57M | Buy |
597,500
+109,400
| +22% | +$1.02M | 1.33% | 21 |
|
|
2023
Q1 | $4.33M | Sell |
488,100
-46,900
| -9% | -$416K | 1.3% | 26 |
|
|
2022
Q4 | $2.66M | Buy |
535,000
+314,350
| +142% | +$1.57M | 0.93% | 31 |
|
|
2022
Q3 | $1.28M | Buy |
220,650
+188,350
| +583% | +$1.09M | 0.53% | 27 |
|
|
2022
Q2 | $179K | Buy |
+32,300
| New | +$179K | 0.08% | 45 |
|